compounded glp-1 drugs New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these at scale. Our Compound versions of GLP-1 drugs
Description
doi: 10.1016/j.diabres.2024.111675, 3

doi:10.1016/j.bbrc.2019.04.160 55

But these days, the language of insanity is exactly how many people describe our society-level problems with chatbots

doi: 10.1080/14656566.2017.1323878
